Walking tied to lower risk for breast cancer
10/07/2013
A large study published recently in the journal Cancer Epidemiology, Biomarkers, and Prevention found that walking was linked to a lower risk for breast cancer in women who have gone through menopause, and for whom walking was their only form of physical activity in leisure time. The findings add to a growing pile of evidence linking regular exercise with lower risk for breast cancer...
Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CPI-613, the Company's lead Altered Energy Metabolism Directed (AEMD) drug candidate, for the treatment of myelodysplastic syndrome (MDS)...
A one-two punch against cancer: American Chemical Society podcast
10/07/2013
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series* describes the development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Based on a report by Nathan Luedtke, Ph.D...
Vaccine acceptance put at risk by neglect of 'science communication environment'
10/07/2013
The biggest threat to the contribution that childhood vaccines make to societal well-being doesn't come from deficits in public comprehension, distrust of science, or misinformation campaigns, but rather from the failure of governmental and other institutions to use evidence-based strategies to anticipate and avoid recurring threats to the science communication environment - th...
Active ingredient of ipecac syrup inhibits growth of bladder cancer cells
10/07/2013
An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer. Years ago ipecac syrup was used to induce vomiting in poisoning cases...
A one-two punch against cancer: American Chemical Society podcast
10/07/2013
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series* describes the development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Based on a report by Nathan Luedtke, Ph.D...
Vaccine acceptance put at risk by neglect of 'science communication environment'
10/07/2013
The biggest threat to the contribution that childhood vaccines make to societal well-being doesn't come from deficits in public comprehension, distrust of science, or misinformation campaigns, but rather from the failure of governmental and other institutions to use evidence-based strategies to anticipate and avoid recurring threats to the science communication environment - th...
Researchers discover how cell dark matter may drive cancer
10/07/2013
University of Montreal researchers have discovered how telomerase, a molecule essential for cancer development, is directed to structures on our genome called telomeres in order to maintain its integrity and in turn, the integrity of the genome...
Sieving through 'junk' DNA reveals disease-causing genetic mutations
10/07/2013
Researchers can now identify DNA regions within non-coding DNA, the major part of the genome that is not translated into a protein, where mutations can cause diseases such as cancer. Their approach reveals many potential genetic variants within non-coding DNA that drive the development of a variety of different cancers. This approach has great potential to find other disease-causing variants...
Target for drug development identified for triple-negative breast cancer
10/07/2013
Often deadly "triple-negative" breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, according to a UC San Francisco researcher who described her discovery in a study published online in the journal Cancer Cell...